Impax Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$15.3M Buy
179,713
+169,106
+1,594% +$13.9M 0.91% 43
2018
Q1
$821K Buy
10,607
+1,518
+17% +$122K 0.05% 156
2017
Q4
$768K Buy
9,089
+794
+10% +$67.6K 0.04% 146
2017
Q3
$710K Buy
8,295
+500
+6% +$41K 0.04% 150
2017
Q2
$642K Buy
7,795
+800
+11% +$65.3K 0.04% 151
2017
Q1
$588K Buy
6,995
+400
+6% +$32K 0.03% 156
2016
Q4
$485K Buy
6,595
+200
+3% +$14.9K 0.03% 156
2016
Q3
$513K Buy
6,395
+500
+8% +$40K 0.03% 155
2016
Q2
$464K Sell
5,895
-100
-2% -$7.53K 0.03% 162
2016
Q1
$432K Buy
5,995
+903
+18% +$68.3K 0.02% 185
2015
Q4
$429K Sell
5,092
-1,600
-24% -$133K 0.02% 173
2015
Q3
$560K Hold
6,692
0.03% 170
2015
Q2
$559K Buy
6,692
+2,497
+60% +$190K 0.03% 166
2015
Q1
$305K Buy
4,195
+18
+0.4% +$1.28K 0.02% 182
2014
Q4
$288K Buy
4,177
+604
+17% +$40.8K 0.02% 182
2014
Q3
$232K Buy
+3,573
New +$226K 0.02% 182

Other funds holding LLY

Impax Asset Management's LLY Position: Q2 2018 in Review

Impax Asset Management increased its Eli Lilly (LLY) stake by 1,594% in Q2 2018, buying an estimated $13.9M and bringing the position to 179,713 shares worth $15.3M. The position accounts for 0.91% of the portfolio, ranked #43.

Impax Asset Management first reported a position in LLY in Q3 2014 and has held it in 16 quarters since. 1,369 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Impax Asset Management held 179,713 shares of Eli Lilly worth $15.3M as of Q2 2018.
  • Impax Asset Management bought 169,106 Eli Lilly shares in Q2 2018, an estimated $13.9M.
  • Eli Lilly made up 0.91% of Impax Asset Management's portfolio in Q2 2018, its #43 holding.
  • Impax Asset Management first reported a position in Eli Lilly in Q3 2014 and has held it in 16 quarters since.
  • 1,369 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.